ClinicalTrials.Veeva

Menu

Pergolide Treatment for Substance Abusers - 4

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Substance-Related Disorders
Cocaine-Related Disorders

Treatments

Drug: Pergolide

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000269
NIDA-09236-4
P50-09236-4

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.

Sex

Male

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems